Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial

202244 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Clinical Microbiology and Infection

Volume 29, Issue 3, pp. 372-378

Field-Weighted Citation Impact: 4.15